ATA43587A - Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen - Google Patents

Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen

Info

Publication number
ATA43587A
ATA43587A AT0043587A AT43587A ATA43587A AT A43587 A ATA43587 A AT A43587A AT 0043587 A AT0043587 A AT 0043587A AT 43587 A AT43587 A AT 43587A AT A43587 A ATA43587 A AT A43587A
Authority
AT
Austria
Prior art keywords
malignal
cells
detecting
producing
monoclonal antibody
Prior art date
Application number
AT0043587A
Other languages
English (en)
Other versions
AT400577B (de
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of ATA43587A publication Critical patent/ATA43587A/de
Application granted granted Critical
Publication of AT400577B publication Critical patent/AT400577B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT0043587A 1986-02-26 1987-02-26 Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen AT400577B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,172 US5185432A (en) 1986-02-26 1986-02-26 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas

Publications (2)

Publication Number Publication Date
ATA43587A true ATA43587A (de) 1995-06-15
AT400577B AT400577B (de) 1996-01-25

Family

ID=25266276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0043587A AT400577B (de) 1986-02-26 1987-02-26 Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen

Country Status (28)

Country Link
US (1) US5185432A (de)
JP (1) JPS62220197A (de)
KR (2) KR870008026A (de)
CN (1) CN87100927A (de)
AT (1) AT400577B (de)
AU (1) AU612967B2 (de)
BE (1) BE1000611A5 (de)
CA (1) CA1312025C (de)
CH (1) CH675880A5 (de)
DD (2) DD276165A5 (de)
DE (1) DE3705276A1 (de)
DK (1) DK98187A (de)
ES (1) ES2004245A6 (de)
FI (1) FI870764A (de)
FR (1) FR2596062B1 (de)
GB (1) GB2186885B (de)
GR (1) GR870294B (de)
IE (1) IE60286B1 (de)
IT (1) IT1203511B (de)
LU (1) LU86786A1 (de)
NL (1) NL8700415A (de)
NO (1) NO174719C (de)
NZ (1) NZ219338A (de)
OA (1) OA08485A (de)
PT (1) PT84370B (de)
SE (2) SE467988B (de)
YU (1) YU46189B (de)
ZA (1) ZA869494B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung
JPH0813840B2 (ja) * 1987-03-31 1996-02-14 協和醗酵工業株式会社 抗ヒト肺腺癌単クロ−ン性抗体
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0863402B1 (de) 1997-03-03 2005-09-14 Amersham Biosciences UK Limited In-situ Zellextraktion und Assay-Verfahren
DE19725133A1 (de) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Nachweis von seltenen Zellen
US20050089918A1 (en) * 1998-02-23 2005-04-28 Amersham Biosciences Uk Limited In-situ cell extraction and assay method
US6117981A (en) * 1999-06-03 2000-09-12 Cytoclonal Pharmaceutics, Inc. Hybridomas for lung cancer marker and monoclonal antibodies thereof
WO2001018021A1 (en) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. B7-like polynucleotides, polypeptides, and antibodies
EP1292619B1 (de) 2000-06-06 2008-02-06 Bristol-Myers Squibb Company Nukleinsäuren und polypeptide, die sich auf b7 beziehen und ihre verwendungen zur immunmodulierung
TWI317285B (en) * 2000-07-28 2009-11-21 Dainippon Sumitomo Pharma Co New use and kit for remedies for cancer
CN101724072B (zh) * 2008-10-27 2013-10-09 谷为岳 一种抗肿瘤的单克隆抗体的序列及应用
GB0916686D0 (en) * 2009-09-23 2009-11-04 Univ Manchester Metropolitan Treatment of cancer
US8802091B2 (en) 2010-03-04 2014-08-12 Macrogenics, Inc. Antibodies reactive with B7-H3 and uses thereof
PE20170779A1 (es) 2010-03-04 2017-07-04 Macrogenics Inc Anticuerpos reactivos con b7-h3, fragmentos inmunologicamente activos de los mismos y usos de los mismos
EP2617730B1 (de) * 2010-09-17 2018-03-07 National Institute of Advanced Industrial Science And Technology Lungenkrebs-differenzialmarker
CN102391992B (zh) * 2011-11-03 2012-08-29 潘世扬 抗人非小细胞肺癌单克隆抗体及其应用
UA127341C2 (uk) 2016-04-15 2023-07-26 Мекроудженікс, Інк. Виділена b7-н3-зв'язувальна молекула
CN111662371B (zh) * 2020-04-30 2023-07-04 美康生物科技股份有限公司 细胞角蛋白19片段抗原及其制备方法和应用
CN112300284B (zh) * 2020-12-29 2021-04-06 慈达(广州)生物技术有限公司 核酸筛选结合抗体检测用于癌症检测中的用途及其制备的试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
ZA858371B (en) * 1984-11-02 1987-03-25 Oncogen Monoclonal antibodies for human non-small cell lung carcinomas
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies

Also Published As

Publication number Publication date
IE870487L (en) 1987-08-26
KR870008026A (ko) 1987-09-23
GB8703700D0 (en) 1987-03-25
DD276165A5 (de) 1990-02-14
IT8719491A0 (it) 1987-02-25
ES2004245A6 (es) 1988-12-16
PT84370A (en) 1987-03-01
DK98187D0 (da) 1987-02-25
SE8700805D0 (sv) 1987-02-25
SE9201529A0 (sv) 1992-05-14
YU46189B (sh) 1993-05-28
SE8700805L (sv) 1987-10-22
SE467988B (sv) 1992-10-12
ZA869494B (en) 1987-10-28
OA08485A (fr) 1988-07-29
NL8700415A (nl) 1987-09-16
NO174719C (no) 1994-06-22
DD266028A5 (de) 1989-03-22
IE60286B1 (en) 1994-06-29
CN87100927A (zh) 1988-10-05
GB2186885A (en) 1987-08-26
FR2596062B1 (fr) 1990-06-08
KR900006338B1 (ko) 1990-08-28
BE1000611A5 (fr) 1989-02-21
GR870294B (en) 1987-06-30
NO174719B (no) 1994-03-14
AU612967B2 (en) 1991-07-25
US5185432A (en) 1993-02-09
KR880010438A (ko) 1988-10-08
DE3705276A1 (de) 1987-08-27
AT400577B (de) 1996-01-25
JPS62220197A (ja) 1987-09-28
YU25787A (en) 1990-12-31
PT84370B (pt) 1989-11-10
FR2596062A1 (fr) 1987-09-25
FI870764A (fi) 1987-08-27
CH675880A5 (de) 1990-11-15
NO870770L (no) 1987-08-27
AU6927287A (en) 1987-08-27
IT1203511B (it) 1989-02-15
NO870770D0 (no) 1987-02-25
FI870764A0 (fi) 1987-02-23
GB2186885B (en) 1990-10-03
CA1312025C (en) 1992-12-29
SE9201529D0 (sv) 1992-05-14
NZ219338A (en) 1991-11-26
DK98187A (da) 1987-08-27
LU86786A1 (fr) 1987-09-15

Similar Documents

Publication Publication Date Title
ATA43587A (de) Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen
DE3788026D1 (de) Verfahren und Vorrichtung zur Kultivierung von Zellen.
DE3854334D1 (de) Verfahren und Gerät zur Bestimmung von Substanzen.
DE68905522D1 (de) Einrichtung und verfahren zur kultur in einem hohlfaserbioreaktor.
DE68928851T2 (de) Vorrichtung und Verfahren zum Herstellen von Informationssträgern
DE3481644D1 (de) Verfahren zum optischen nachweis von parametern von substanzen in einem fluessigen analyt.
ATA150386A (de) Verfahren zur herstellung eines mikrokristallinen schleifmaterials
DE3788058D1 (de) Zelltoxischer antikörperkomplex und verfahren zu seiner herstellung.
DE3682357D1 (de) Probemittel, verfahren zu seiner herstellung und verfahren zur bestimmung einer komponente in einer probe.
DE3673527D1 (de) Verfahren und vorrichtung zur bestimmung von parametern gasfoermiger substanzen.
ATA208987A (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
AT400120B (de) Verfahren und vorrichtung zur herstellung von dachsteinen
DE69028029D1 (de) Dünnschichtige retroreflektierende Übertragungsfolie und Verfahren zu deren Herstellung
DE68912661D1 (de) Verfahren und Vorrichtung für Zellkultur.
DE3783209D1 (de) Verfahren und apparat zur bestimmung von immunologischen reaktiven substanzen von klinischem interesse.
DE3775641D1 (de) Entmetallisierung eines katalysators und verfahren zur verwendung eines entmetallisierten katalysators.
DE3880565D1 (de) Einrichtung und verfahren zur inspektion von kernreaktor-brennelementen.
DE3855153D1 (de) Verfahren zum klassifizieren von leukozyten und reagenzien
DE3788352D1 (de) Verfahren zur herstellung eines heterologen proteins in insektenzellen.
DE68927174D1 (de) Verfahren zur herstellung von weichem stahlmaterial
AT386545B (de) Verfahren zum reinigen von gasen sowie vorrichtung zur durchfuehrung dieses verfahrens
DE69030682D1 (de) Verfahren und Vorrichtung zum Bilden von Sätzen
ATA32586A (de) Verfahren zur herstellung eines trisubstituierten n-phenylharnstoffes
AT383424B (de) Verfahren zum nachweis von antikoerpern und verfahren zur herstellung eines mittels zum nachweis von antikoerpern
DE3676240D1 (de) Verfahren zur verwendung eines binaeren registers mit n-bistabilen zellen zur bestimmung des verhaeltnisses zweier frequenzen und vorrichtung zur durchfuehrung des verfahrens.

Legal Events

Date Code Title Description
EENE Nomination of inventor
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee